These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8352543

  • 1. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Willén R, Himmelmann A, Långström-Einarsson E, Fernö M, Ranstam J, Baldetorp B, Skjaerris J, Prien-Larsen J, Tropé C, Stendahl U.
    Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
    [Abstract] [Full Text] [Related]

  • 2. Prospective malignancy grading and flow cytometry DNA distribution in biopsy specimens from invasive squamous cell carcinoma of the uterine cervix.
    Willén R, Tropé C, Långström E, Ranstam J, Killander D, Clase L.
    Anticancer Res; 1987; 7(2):235-42. PubMed ID: 3592637
    [Abstract] [Full Text] [Related]

  • 3. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG.
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [Abstract] [Full Text] [Related]

  • 4. Prospective malignancy grading of invasive squamous carcinoma of the uterine cervix. Prognostic significance in a long-term follow-up.
    Lindahl B, Ranstam J, Willén R.
    Anticancer Res; 2007 Jun; 27(4C):2829-32. PubMed ID: 17695455
    [Abstract] [Full Text] [Related]

  • 5. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
    Lutgens LC, Schutte B, de Jong JM, Thunnissen FB.
    Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
    [Abstract] [Full Text] [Related]

  • 6. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J.
    J Clin Oncol; 2003 Nov 15; 21(22):4214-21. PubMed ID: 14615450
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH, Wu LY, Bai P, Li SM, Zhang R, Li B, Sun JH, Wu AR.
    Zhonghua Zhong Liu Za Zhi; 2004 Aug 15; 26(8):490-2. PubMed ID: 15555341
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB, Kim GE, Cho NH, Pyo HR, Shim SJ, Chang SK, Park HC, Suh CO, Park TK, Kim BS.
    Cancer; 2002 Aug 01; 95(3):531-9. PubMed ID: 12209745
    [Abstract] [Full Text] [Related]

  • 9. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY.
    Gynecol Oncol; 1999 May 01; 73(2):184-90. PubMed ID: 10329032
    [Abstract] [Full Text] [Related]

  • 10. [Flow cytometric DNA analysis and neoadjuvant chemotherapy of cervix cancer (stage IB2-IIIB)].
    Kornovskiĭ Ia, Gorchev G, Balev S, Ivanova F.
    Akush Ginekol (Sofiia); 2004 May 01; 43(3):37-41. PubMed ID: 15341256
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Cancer Radiother; 2005 Dec 01; 9(8):575-86. PubMed ID: 16243560
    [Abstract] [Full Text] [Related]

  • 15. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N.
    Gynecol Oncol; 2004 Jun 01; 93(3):628-31. PubMed ID: 15196855
    [Abstract] [Full Text] [Related]

  • 16. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL, Anderson PS, Goldberg GL, Wadler S, Beitler J, Sood B, Runowicz CD.
    Gynecol Oncol; 1996 Jun 01; 61(3):416-22. PubMed ID: 8641625
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognosis of early cervical cancer (FIGO Stages IA2, IB, and IIA) in northern Norway predicted by malignancy grading score and objective morphometric image analysis.
    Eggen T, Arnes M, Moe B, Straume B, Orbo A.
    Int J Gynecol Pathol; 2007 Oct 01; 26(4):447-56. PubMed ID: 17885497
    [Abstract] [Full Text] [Related]

  • 19. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM.
    Gynecol Oncol; 1993 Feb 01; 48(2):232-5. PubMed ID: 8428696
    [Abstract] [Full Text] [Related]

  • 20. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y, Gorchev G.
    J BUON; 2007 Feb 01; 12(1):57-63. PubMed ID: 17436403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.